CLINICAL_TRIALS
trial_result
· 2021-05-14
Clinical Trial Update: Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating fulvestrant in combination with enzalutamide for ER+/HER2- advanced breast cancer has completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-05-14